Xenetic Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Xenetic Biosciences

12/05/2023 24:58

* Xenetic Biosciences Inc  XBIO.OQ  reported a quarterly
adjusted
loss of 6 cents​​ per share for the quarter ended in March. The
lone analyst forecast for the quarter was for a loss of 11 cents
per share.
    * Revenue rose 55.7% to $605.84 thousand from a year ago;
analysts
expected $410.00 thousand. 
    * Xenetic Biosciences Inc's reported EPS for the quarter was
a
loss of 6 cents​.
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Xenetic Biosciences Inc shares had fallen by 1.0% this
quarter and gained 41.0% so far this year.
    * The company reported a quarterly loss of $856.55 thousand.
    * Wall Street's median 12-month price target for Xenetic
Biosciences Inc is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 11:58 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.11          -0.06          Beat
 Dec. 31 2022      -0.09          -0.10          Missed
 Sep. 30 2022      -0.18          -0.06          Beat
 Jun. 30 2022      -0.12          -0.19          Missed